Systems-level restoration of vaginal and gut microbiota by Lactobacillus helveticus 20838 alleviates Gardnerella vaginalis -induced dysbiosis
The ISME Journal · 2026
DOI: 10.1093/ismejo/wrag118 ↗Kurz gefasst
Fachartikel in der Zeitschrift The ISME Journal, 2026. Verfasst von Juewon Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Konkuk University College of Medicine, Chungju 27478, Republic of Korea. Hauptthemen laut MEDLINE: Dysbiosis, Lactobacillus helveticus, Vagina, Probiotics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Konkuk University.
Abstract (Originalsprache)
Bacterial vaginosis (BV), often driven by Gardnerella vaginalis overgrowth, is characterized by epithelial disruption, inflammation, and microbiome dysbiosis across the vaginal and gut ecosystems. Affecting a majority of women during their reproductive years, BV increases the risk of infection and reproductive complications. Here, we identify a novel probiotic strain, Lactobacillus helveticus 20838, exhibiting potent antagonistic activity against G. vaginalis and evaluate its ecological and immunological effects in a murine model of vaginitis. Comparative genomics revealed distinct adaptive and antimicrobial traits of L. helveticus 20838 relatives to the reference strain DPC4571. Both oral and intravaginal administration reduced G. vaginalis colonization, suppressed Tnf-α and Il-1β expression in vaginal tissue, and prevented pathological epithelial thickening. Multi-omics profiling of fecal and vaginal samples demonstrated restoration of microbial alpha and beta diversity disrupted by infection. The L. helveticus 20838 reduced dysbiosis-associated taxa such as Staphylococcaceae, whereas enriching protective Lactobacillus species, with intravaginal delivery achieving superior local recolonization of Lactobacillaceae. Collectively, these findings identify L. helveticus 20838 as a next-generation probiotic that alleviates G. vaginalis–induced dysbiosis by restoring microbial and immune homeostasis across interconnected mucosal niches, providing a systems-level framework for microbiota-targeted therapy in women’s health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, Konkuk University College of Medicine, Chungju 27478, Republic of Korea.
- HEM Pharma Inc., Suwon 16506, Republic of Korea.
- Microbiome Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
ORCID-Profile: Juewon Kim
Förderung
- Konkuk University
Zitieren
APA
Kim, J., Kim, W. I., Lee, K., Kim, N., Hwang, A. Y., Suh, D. H., Cho, D., Ji, Y., Kang, H. J., & Jung, E. S. (2026). Systems-level restoration of vaginal and gut microbiota by Lactobacillus helveticus 20838 alleviates Gardnerella vaginalis -induced dysbiosis. The ISME Journal. https://doi.org/10.1093/ismejo/wrag118
Vancouver
Kim J, Kim WI, Lee K, Kim N, Hwang AY, Suh DH, et al. Systems-level restoration of vaginal and gut microbiota by Lactobacillus helveticus 20838 alleviates Gardnerella vaginalis -induced dysbiosis. The ISME Journal. 2026. doi:10.1093/ismejo/wrag118
BibTeX
@article{Kim2026,
author = {Kim, Juewon and Kim, Woo-Il and Lee, Kyuyeon and Kim, Nayeon and Hwang, Ah Young and Suh, Dong Ho and Cho, Donghyun and Ji, Yosep and Kang, Hye-Ji and Jung, Eun Sung},
title = {Systems-level restoration of vaginal and gut microbiota by Lactobacillus helveticus 20838 alleviates Gardnerella vaginalis -induced dysbiosis},
journal = {The ISME Journal},
year = {2026},
doi = {10.1093/ismejo/wrag118}
}
EUVIMED